After transplant, recovery of bone health may be impaired by nutritional vitamin D deficiency, persistent hyperparathyroidism, tertiary FGF-23 excess, hypophosphatemia, immunosuppressive therapy with corticosteroids and/or calcineurin inhibitors (CNI), and alteration of sex hormones. The gene discussed is FGF23; the disease is vitamin D deficiency.